{"title":"在2型糖尿病的一线治疗中,2型钠-葡萄糖共转运体抑制剂可能与二甲双胍一样有益","authors":"M. V. Salgado","doi":"10.51987/evidencia.v26i1.7038","DOIUrl":null,"url":null,"abstract":"2 sodium-glucose cotransporter inhibitors could be as beneficial as metformin for the first-line treatment of type 2 diabetes","PeriodicalId":34114,"journal":{"name":"Evidencia Actualizacion en la Practica Ambulatoria","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Los inhibidores del cotransportador sodio-glucosa tipo 2 podrían resultar igual de beneficiosos que la metformina para el tratamiento de primera línea de la diabetes tipo 2\",\"authors\":\"M. V. Salgado\",\"doi\":\"10.51987/evidencia.v26i1.7038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"2 sodium-glucose cotransporter inhibitors could be as beneficial as metformin for the first-line treatment of type 2 diabetes\",\"PeriodicalId\":34114,\"journal\":{\"name\":\"Evidencia Actualizacion en la Practica Ambulatoria\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidencia Actualizacion en la Practica Ambulatoria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51987/evidencia.v26i1.7038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidencia Actualizacion en la Practica Ambulatoria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51987/evidencia.v26i1.7038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Los inhibidores del cotransportador sodio-glucosa tipo 2 podrían resultar igual de beneficiosos que la metformina para el tratamiento de primera línea de la diabetes tipo 2
2 sodium-glucose cotransporter inhibitors could be as beneficial as metformin for the first-line treatment of type 2 diabetes